Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension


ŞENGÜL C., Cevik C., Ozveren O., Oduncu V., Sunbul A., Kilicarslan F., ...Daha Fazla

Journal of Electrocardiology, cilt.45, sa.2, ss.123-128, 2012 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 45 Sayı: 2
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.jelectrocard.2011.09.004
  • Dergi Adı: Journal of Electrocardiology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.123-128
  • Anahtar Kelimeler: Atrial electromechanical delay, Atrial fibrillation, Eechocardiography, Telmisartan
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Background: Atrial electromechanical delay (EMD) parameters predict the development of atrial fibrillation. We investigated the effect of telmisartan treatment on atrial EMD parameters in patients with newly diagnosed essential hypertension. Methods: Thirty-six patients with essential hypertension were treated with telmisartan (80 mg/day) for 6 months. Baseline electrocardiographic P-wave measurements and echocardiographic atrial EMD parameters were compared with the 6-month follow-up. Results: Pmax and Pd were significantly decreased (108.4 ± 6.1 vs 93.9 ± 6.2 milliseconds, 33.4 ± 8.6 vs 19.5 ± 7.0 milliseconds, respectively, P =.0001 for each) after 6-month telmisartan therapy. The atrial EMD parameters were decreased from baseline (mitral EMD, 68.9 ± 4.9 vs 53.8 ± 4.9 milliseconds; septum EMD, 51.6 ± 7.1 vs 42.6 ± 7. milliseconds1; tricuspid EMD, 48 ± 6.9 vs 39 ± 6.9 milliseconds; interatrial EMD, 20.9 ± 5.5 vs 14.8 ± 5.7 milliseconds; P =.0001 for each parameter). The reduction of interatrial EMD was correlated with the reduction in systolic BP nighttime and the increase in mitral E wave velocity/mitral A wave velocity ratio. Conclusion: Telmisartan decreased the atrial EMD parameters in patients with newly diagnosed essential hypertension. © 2012 Elsevier Inc.